BioSpace News Archive

UroGen Pharma Ltd. announced that it will present at the following investor conferences in September.

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”) today reported the publication of a research article entitled “Immunological, Oxidative, and Structural Factors and Their Responses to Regulatory T Lymphocyte Therapy in Amyotrophic Lateral Sclerosis” in the peer-reviewed journal Ageing and Neurodegenerative Diseases.

Orthofix Medical Inc., a leading global spine and orthopedics company, announced that the Company will participate in the Morgan Stanley Healthcare Conference in New York City.

BriaCell Therapeutics Corp. announces that it has accepted a letter of intent from Dr. Massimo Cristofanilli, Director of Breast Medical Oncology and Associate Director of Precision Medicine in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, outlining the parties’ plans and commitment, upon regulatory approval, to initiate a Phase 2 investigator-initiated clinical study to evaluate BriaCell’s novel immunotherapy, Bria-IMT™.

Cerevance today announced plans to present an oral presentation at the upcoming 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium, taking place in Cambridge, United Kingdom, September 10 – 13th, 2023.

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced the appointment of Juan Pablo Frías, M.D. as Chief Medical Officer (CMO).

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board of Directors and as Chair of its Audit Committee, effective immediately.

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that management will participate in two investor conferences in September.

The International Myeloma Foundation announced that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global Vice President of Patient Engagement & Advocacy.

Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2023 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 7.